AMD

This study tested an experimental drug called ALK-001 in people with geographic atrophy, an advanced form of dry age-related macular degeneration that causes blind spots. About 200 participants received the drug and 100 received a placebo. The main goal was to see if ALK-001 coul…

This study looked at 30 people with a common eye disease called wet AMD. Researchers measured protein levels in the fluid at the front of the eye to see how the eye's natural barrier works during treatment. The goal was to better understand the disease, not to test a new treatmen…

This study looked at 60 people with geographic atrophy, an advanced form of dry age-related macular degeneration that causes permanent vision loss. Researchers reviewed past eye exams and scans to see how vision loss relates to changes in the retina. No new treatments were tested…

This study tested a new, noninvasive eye scan called OCT angiography to see how blood vessels change in people with wet age-related macular degeneration (AMD) during treatment. Researchers looked at 49 patients to find early signs of the disease coming back. The goal was to learn…